Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Elevar Therapeutics in the transaction, and Goodwin Procter advised Relay Therapeutics. Elevar Therapeutics, Inc. (Elevar), a majority-owned subsidiary...
Elevar Therapeutics’ Global Licensing Agreement with Relay Therapeutics
Relay Therapeutics’ $200 Million Follow-on Offering
Goodwin Procter and Dechert advised Relay Therapeutics, Inc. in the offering, and Ropes & Gray advised the underwriters. Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision...